1-es típusú cukorbetegség: vizsgálatok itt: Finnország
9 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Oulu, Tampere, Turku
- Életkor
- 1 év to 35 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Helsinki, Oulu, Tampere, Turku
- Életkor
- 1 év to 35 év
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - 2. fázisNot yet taking people in FinnországdApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
- Where
- Helsinki, Turku
- Életkor
- 18 év to 64 év
- People
- 36 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06072326 · EU 2026-525684-40-01 - No phaseTaking peopleThe Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment
- Where
- Espoo, Helsinki
- Életkor
- 7 év to 16 év
- People
- 100
- Run by
- Helsinki University Central Hospital
See details and how to joinNCT07423637 - 2. fázisTaking peopleSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Where
- Helsinki, Turku
- Életkor
- 5 év to 40 év
- People
- 159 worldwide
- Run by
- SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Helsinki
- Életkor
- 18 év to 99 év
- People
- 24 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseCsak meghívásosFinnDiane LifeOne Study - Impact of Ageing on People With Type 1 Diabetes
- Where
- Helsinki
- Életkor
- 65 év and over
- People
- 400
- Run by
- Helsinki University Central Hospital
See details and how to joinNCT07289204 - No phaseTaking peopleNoninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics
- Where
- Turku
- Életkor
- 18 év to 45 év
- People
- 60
- Run by
- Turku University Hospital
See details and how to joinNCT06343974 - No phaseTaking peopleTrialNet Pathway to Prevention of T1D
- Where
- Turku
- Életkor
- 2 év to 45 év
- People
- 75 000 worldwide
- Run by
- University of South Florida
See details and how to joinNCT00097292